ABSTRACT

The risk of developing tuberculosis (TB) is long associated with diabetes. DM is becoming more and more prevalent all over the world. The linked burden of TB and diabetes has received considerable attention. Diabetes can double to triple the risk of contracting tuberculosis. In addition, TB may promote hyperglycemia and decrease glycaemic control in diabetics. Moreover, it raises the chances of failure of TB therapy, symptom exacerbation, and even premature death. Concern for epidemics interacting with TB and diabetes in low-income countries including India, China, Indonesia, Pakistan, and South Africa has been highlighted by healthcare experts. In 2021, 10.6 million people were confirmed diagnosed with TB while 1.6 million lives have been lost due to TB. It is also the second most common infectious killer in the globe, behind COVID-19, and the 13th greatest cause of death globally. Extensive healthcare improvement and unification might well be required to maintain these elevated risks in patients' care after the completion of their TB treatment. Keywords: Diabetes, Tuberculosis, glycaemic control
Publication date: 01/06/2024

https://ijbpas.com/pdf/2024/June/MS_IJBPAS_2024_8103.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2024/13.6.8103